Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2776591 | Journal of the American Society of Cytopathology | 2015 | 7 Pages |
Abstract
In this study, 15.4% of pericardial effusion cases were caused by metastatic malignancy, with lung adenocarcinoma being the most common primary site, followed by breast and lymphoma. Relatively young patients are affected, with average age being 56 years. Prognosis is poor for patients with malignant pericardial effusion. However, targeted therapy showed improved survival.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
Authors
Hui MD, PhD, Christine N. MD, Jordan P. MD,